Deana Mohr-Haralampieva

CEO & Co-Founder at MUVON Therapeutics - a Swiss biotechnology start-up with the goal of developing and commercializing an autologous cell therapy for the regeneration of skeletal muscle tissue, focusing initially on the treatment of stress urinary incontinence.